- Participants in our Network
- Gender studies
- Education and Teaching
- Updates, Event Notices, Schedules
-
Archive
- Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat
- Multidisciplinary management of meningiomas in the era of precision oncology
- Spatial single cell transcriptomic analysis informs tumor developmental hierarchy of DICER1 syndrome related sarcoma
- From Anatomy to Outcome: Linking Glioma Location Patterns to Survival Using Non-Negative Matrix Factorization
- Prognostic impact of radiotherapy timing in WHO grade 2 and 3 meningiomas utilizing an integrated molecular-morphologic classification
- Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas
- The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland
- Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysis
- Artificial intelligence pipeline predicts the integrated molecular-morphologic risk score of meningiomas from routine preoperative MRI
- Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma Patients
- A comparative analysis of CD70-directed CAR-T cells for glioblastoma treatment demonstrates a superior efficacy of the ligand-based construct
- MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma
- The prognostic impact of CDKN2A/B hemizygous deletions in meningioma
- A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification
- GREB1-rearranged uterine tumour shares a common DNA methylation signature with ESR1-rearranged UTROSCT
- Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment Strategies
- PTEN deficiency linked to chromosome 10q loss leads to aggressive NF2 mutant meningioma biology
- IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
- Early distant progression in adult Histone-3 K27-altered diffuse midline gliomas
- Primary Cutaneous SWI/SNF-Deficient Carcinomas: Morphologic, Immunohistochemical, and Molecular Analysis of Seven Cases
About our Network
The Network Gendermedicine Heidelberg is a multidisciplinary initiative that connects researchers and clinicians from the Medical Faculty of Heidelberg University, the University Hospital Heidelberg, DKFZ, DZL, EMBL as well as the Medical Faculty and University Hospital Mannheim. Its core mission is to systematically integrate sex and gender aspects into biomedical research, clinical practice, and academic teaching. The network brings together basic researchers, clinicians, educators, and advocates from diverse fields to work collaboratively towards a more inclusive and equitable healthcare system.
The activities of our network encompass the organization of scientific events and research colloquia, science communication initiatives, and the coordination of educational programs. Through these efforts, we aim to strengthen the integration of gender medicine in Heidelberg's research, teaching, policy, and public discourse.
Our activities spark new knowledge, strengthen the quality and competitiveness of scientific innovation, and lead to the optimal exploitation of knowledge and expertise to improve healthcare for women, men, boys, girls, and gender diverse people. At the same time, we are committed to promoting equal participation of all genders in research, leadership, and healthcare delivery, while establishing a common scientific and clinical platform for gender-sensitive research and care.
Why Gendermedicine Matters
According to the recommendation of The German Science and Humanities Council in 2023 (https://www.wissenschaftsrat.de/download/2023/1385-23), the systematic consideration of sex- and gender-related aspects in medicine is the first step toward the efficient implementation of precision medicine that aims to improve the quality and equity of health care for all.
Men and women differ significantly in terms of disease prevalence, symptomatology, treatment response, and outcomes. Despite this, traditional biomedical research and healthcare systems have often been designed around a 'male norm'. This has led to diagnostic gaps, less effective treatments for women, and overlooked health needs across the whole gender spectrum.
Examples of gender-related differences in medicine include:
- Women and men show different symptoms during myocardial infarction, often leading to delayed diagnosis in women.
- Women are more likely to develop Alzheimer’s disease, autoimmune disorders, and thyroid dysfunctions.
- Men are at higher risk for Parkinson’s disease and have higher mortality rates from infectious diseases like COVID-19.
- Many preclinical studies rely predominantly on male cells and male animal models, and clinical trials often lack gender balance or disaggregated data analysis.
Incorporating sex- and gender- related analysis into medicine is a prerequisite for precision medicine. It enhances diagnostic accuracy, optimizes therapeutic outcomes, and improves patient-centered care for all individuals, including men, women, and gender-diverse populations. The ultimate goal of gender medicine is to provide clinicians with the necessary data and tools to integrate gender-related aspects into clinical practice as well as public health. Thus, aside from research as a basis for improved clinical care, implementation of gender medicine in teaching and education are an equally important pillar of gender medicine and our network. Medical students need to be taught sex- and gender-aspects in clinical care (e. g. differences in drug therapies, symptoms, etc.), as well as gender-sensitive communication and treatment. This educational approach should extend beyond medicine to encompass related scientific fields such as molecular medicine, biology, and biochemistry, while also incorporating theoretical disciplines like ethics, philosophy, economics, and gender studies.
Get Involved!
Are you interested in contributing to or learning more about gender-sensitive research, education, or clinical practice? The Network Gendermedicine Heidelberg welcomes collaboration with academics, clinicians, students, and stakeholders from all disciplines. Join our mailing list to stay informed about ongoing projects, upcoming events, and opportunities for engagement:
Click here to sign up to our mailing list!
By signing up to our mailing list, you will be able to contact the subscribed members of Network Gendermedicine Heidelberg,
If you have specific questions about the activities of the network, feel free to contact one of the coordinating members of the network:
- PD Dr. Nadia Primc (Associate professor/akademische Rätin at the Institute for the History or Ethics of Medicine), E-Mail: primc(at)uni-heidelberg.de, Tel.: +49 6221 545458
- Prof. Dr. Konstanze Plaschke (Equal Opportunity Officer/Gleichstellungsbeauftragte oft the Medical Faculty Heidelberg), E-Mail: konstanze.plaschke(at)med.uni-heidelberg.de
- Prof. Dr. Franziska Trudzinski (Senior consultant in pneumology and respiratory medicine at the Thorax Clinic of the University Hospital Heidelberg), E-Mail: franziska.trudzinski(at)med.uni-heidelberg.de
- PD Dr. Margarida Souto-Carneiro (Head of Rheumatology Research Laboratory of the linic for Hematology, Oncology, Rheumatology), E-Mail: Margarida.Souto-Carneiro(at)med.uni-heidelberg.de
- Participants in our Network
- Gender studies
- Education and Teaching
- Updates, Event Notices, Schedules
-
Archive
- Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat
- Multidisciplinary management of meningiomas in the era of precision oncology
- Spatial single cell transcriptomic analysis informs tumor developmental hierarchy of DICER1 syndrome related sarcoma
- From Anatomy to Outcome: Linking Glioma Location Patterns to Survival Using Non-Negative Matrix Factorization
- Prognostic impact of radiotherapy timing in WHO grade 2 and 3 meningiomas utilizing an integrated molecular-morphologic classification
- Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas
- The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland
- Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysis
- Artificial intelligence pipeline predicts the integrated molecular-morphologic risk score of meningiomas from routine preoperative MRI
- Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma Patients
- A comparative analysis of CD70-directed CAR-T cells for glioblastoma treatment demonstrates a superior efficacy of the ligand-based construct
- MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma
- The prognostic impact of CDKN2A/B hemizygous deletions in meningioma
- A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification
- GREB1-rearranged uterine tumour shares a common DNA methylation signature with ESR1-rearranged UTROSCT
- Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment Strategies
- PTEN deficiency linked to chromosome 10q loss leads to aggressive NF2 mutant meningioma biology
- IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
- Early distant progression in adult Histone-3 K27-altered diffuse midline gliomas
- Primary Cutaneous SWI/SNF-Deficient Carcinomas: Morphologic, Immunohistochemical, and Molecular Analysis of Seven Cases
Join our mailing list
Stay informed about ongoing projects, upcoming events, and opportunities for engagement: